Andrew Cittadine - Nov 14, 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Operating Officer
Signature
Kim R. Tsuchimoto, Attorney-in-fact
Stock symbol
MNPR
Transactions as of
Nov 14, 2022
Transactions value $
$49,659
Form type
4
Date filed
11/16/2022, 03:58 PM
Previous filing
Oct 3, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Purchase $18.2K +6.05K +73.95% $3.00 14.2K Nov 14, 2022 Direct
transaction MNPR Common Stock Purchase $31.5K +10K +70.23% $3.15 24.2K Nov 15, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.